Forecast

There is no analyst data available for this company.

News Go to news feed

Retractable Technologies confirms three directors to board of directors

Retractable Technologies elected three Class 2 directors to its board of directors at the virtual annual meeting held on May 8, 2026: Thomas J. Shaw, Walter O. Bigby, Jr. and John W. Fort III. The voting results showed overwhelming majorities for all three nominees, with no abstentions or broker non‑votes. Information is based on a filing submitted to the SEC. » More on de.investing.com
Retractable Technologies cuts 12.4% of jobs due to tariff pressure and declining sales

Retractable Technologies has announced plans to cut about 12.4% of its workforce, mainly in production and support areas, in response to tariff pressure and a 16% decline in sales over the past twelve months. The company expects annual savings of around $1.6 million, but continues to face high cash outflows and negative EBITDA. Additionally, following a merger, the company has changed its auditor from Moss Adams to Baker Tilly, with previous audit reports containing no objections. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2024, RETRACTABLE TECHNOLOGIES has already paid €18.88 in dividends. The last payout was in February 2024.

Financials

In the last quarter, RETRACTABLE TECHNOLOGIES had revenue of €6.31M and net profit of €2.48M

(EUR)	Jun 2026	YoY
Revenue	6.31M	28.81%
Gross profit	167.23K	284.05%
Net profit	2.48M	3,442.24%
EBITDA	4.16M	171.01%

Fundamentals

Metric	Value
Market capitalization	€18.65M
Number of shares	29.94M
52-week high/low	€0.98 - €0.52
Dividends	No
Beta	1.21
P/E ratio	-6.00
PEG ratio	0.07
P/B ratio	0.30
P/S ratio	0.64

Company profile

Retractable Technologies, Inc. entwirft, entwickelt, produziert und vermarktet Sicherheitsspritzen und andere medizinische Sicherheitsprodukte für das Gesundheitswesen in den Vereinigten Staaten, dem Rest von Nord- und Südamerika und international. Das Unternehmen bietet VanishPoint-Insulinspritzen, Tuberkulin-, Insulin- und Allergie-Antigen-Spritzen, Adapter für Röhrchen mit kleinem Durchmesser, Halter für Blutentnahmeröhrchen, Allergieschalen, IV-Sicherheitskatheter, Patient Safe-Spritzen und Luer Caps, VanishPoint-Blutentnahmesets, EasyPoint-Nadeln und VanishPoint-Spritzen mit automatischer Entnahme. Das Unternehmen vertreibt seine Produkte über Fachhändler und Spezialhändler sowie über internationale Händler und ein Direktmarketing-Netzwerk. Retractable Technologies, Inc. wurde 1994 gegründet und hat seinen Hauptsitz in Little Elm, Texas.

Name	RETRACTABLE TECHNOLOGIES
CEO	Thomas J. Shaw
Headquarters	Little Elm, tx USA
Website	retractable.com
Sector	Consumer Discretionary
Industry	Household Durables
IPO	10/31/2014
Employees	198